James Wagner, Xinyu Zhang, Michael R Elliott, Brady T West, Stephanie M Coffey
{"title":"An experimental evaluation of a stopping rule aimed at maximizing cost-quality trade-offs in surveys.","authors":"James Wagner, Xinyu Zhang, Michael R Elliott, Brady T West, Stephanie M Coffey","doi":"10.1093/jrsssa/qnad059","DOIUrl":null,"url":null,"abstract":"<p><p>Surveys face difficult choices in managing cost-error trade-offs. Stopping rules for surveys have been proposed as a method for managing these trade-offs. A stopping rule will limit effort on a select subset of cases to reduce costs with minimal harm to quality. Previously proposed stopping rules have focused on quality with an implicit assumption that all cases have the same cost. This assumption is unlikely to be true, particularly when some cases will require more effort and, therefore, more costs than others. We propose a new rule that looks at both predicted costs and quality. This rule is tested experimentally against another rule that focuses on stopping cases that are expected to be difficult to recruit. The experiment was conducted on the 2020 data collection of the Health and Retirement Study (HRS). We test both Bayesian and non-Bayesian (maximum-likelihood or ML) versions of the rule. The Bayesian version of the prediction models uses historical data to establish prior information. The Bayesian version led to higher-quality data for roughly the same cost, while the ML version led to small reductions in quality with larger reductions in cost compared to the control rule.</p>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"9 1","pages":"788-810"},"PeriodicalIF":3.2000,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746548/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology","FirstCategoryId":"100","ListUrlMain":"https://doi.org/10.1093/jrsssa/qnad059","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Surveys face difficult choices in managing cost-error trade-offs. Stopping rules for surveys have been proposed as a method for managing these trade-offs. A stopping rule will limit effort on a select subset of cases to reduce costs with minimal harm to quality. Previously proposed stopping rules have focused on quality with an implicit assumption that all cases have the same cost. This assumption is unlikely to be true, particularly when some cases will require more effort and, therefore, more costs than others. We propose a new rule that looks at both predicted costs and quality. This rule is tested experimentally against another rule that focuses on stopping cases that are expected to be difficult to recruit. The experiment was conducted on the 2020 data collection of the Health and Retirement Study (HRS). We test both Bayesian and non-Bayesian (maximum-likelihood or ML) versions of the rule. The Bayesian version of the prediction models uses historical data to establish prior information. The Bayesian version led to higher-quality data for roughly the same cost, while the ML version led to small reductions in quality with larger reductions in cost compared to the control rule.
调查在管理成本-误差权衡方面面临着困难的选择。有人提出了调查的停止规则,作为管理这些权衡的一种方法。停止规则将限制对特定子集案例的调查,以降低成本,同时将对质量的损害降至最低。以前提出的停止规则侧重于质量,隐含的假设是所有案例都具有相同的成本。这种假设不太可能成立,特别是当某些案例需要付出更多努力,因此成本也会高于其他案例时。我们提出了一种既考虑预测成本又考虑质量的新规则。这条规则与另一条规则进行了实验测试,后者的重点是停止预计难以招募的病例。实验是在健康与退休研究(HRS)2020 年的数据收集中进行的。我们测试了该规则的贝叶斯和非贝叶斯(最大似然法或 ML)版本。贝叶斯版本的预测模型使用历史数据建立先验信息。与对照规则相比,贝叶斯版本以大致相同的成本获得了更高质量的数据,而 ML 版本则以更大的成本降低了数据质量。
期刊介绍:
The International Journal of Cardiology is devoted to cardiology in the broadest sense. Both basic research and clinical papers can be submitted. The journal serves the interest of both practicing clinicians and researchers.
In addition to original papers, we are launching a range of new manuscript types, including Consensus and Position Papers, Systematic Reviews, Meta-analyses, and Short communications. Case reports are no longer acceptable. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.